 | • レポートコード：GIR-2104Z10138 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、肥満症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。肥満症治療の種類別市場規模（手術＆インプラント装置、薬物療法、食事療法、その他）、用途別市場規模（子供、大人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・肥満症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：NutriSystem, Inc. (U.S.)、Kellogg Company (U.S.)、Ethicon, Inc. (U.S.)、Medtronic (U.S.)、F. Hoffmann-La Roche (Switzerland)、Atkins Nutritionals, Inc. (U.S.)、Herbalife Ltd. (U.S.)、Covidien plc (U.S.)、Apollo Endosurgery (U.S.)、Amer Sports (Finland)、Johnson Health Technology, Ltd. (Taiwan)、Cybex International (U.S.)、USGI Medical (U.S.)、Olympus Corporation (Japan)、Brunswick Corporation (U.S.)、Technogym SpA (Italy) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：手術＆インプラント装置、薬物療法、食事療法、その他 ・用途別分析2016年-2026年：子供、大人 ・肥満症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・肥満症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・肥満症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・肥満症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・肥満症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Obesity Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Obesity Treatment size is estimated to be USD 8178.4 million in 2025 from USD 5054.2 million in 2019, with a change XX% between 2019 and 2020. The global Obesity Treatment market size is expected to grow at a CAGR of 12.8% for the next five years.
Market segmentation
Obesity Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Surgical & Implant Devices
Medication Therapy
Dietary
Other
Market segment by Application, can be divided into
Children
Adults
Market segment by players, this report covers
NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Obesity Treatment
1.2 Classification of Obesity Treatment by Type
1.2.1 Overview: Global Obesity Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Obesity Treatment Revenue Market Share by Type in 2020
1.2.3 Surgical & Implant Devices
1.2.4 Medication Therapy
1.2.5 Dietary
1.2.6 Other
1.3 Global Obesity Treatment Market by Application
1.3.1 Overview: Global Obesity Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Children
1.3.3 Adults
1.4 Global Obesity Treatment Market Size & Forecast
1.5 Global Obesity Treatment Market Size and Forecast by Region
1.5.1 Global Obesity Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Obesity Treatment Market Size by Region, (2016-2021)
1.5.3 North America Obesity Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Obesity Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Obesity Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Obesity Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Obesity Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Obesity Treatment Market Drivers
1.6.2 Obesity Treatment Market Restraints
1.6.3 Obesity Treatment Trends Analysis
2 Company Profiles
2.1 NutriSystem, Inc. (U.S.)
2.1.1 NutriSystem, Inc. (U.S.) Details
2.1.2 NutriSystem, Inc. (U.S.) Major Business
2.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Product and Solutions
2.1.4 NutriSystem, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 NutriSystem, Inc. (U.S.) Recent Developments and Future Plans
2.2 Kellogg Company (U.S.)
2.2.1 Kellogg Company (U.S.) Details
2.2.2 Kellogg Company (U.S.) Major Business
2.2.3 Kellogg Company (U.S.) Obesity Treatment Product and Solutions
2.2.4 Kellogg Company (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Kellogg Company (U.S.) Recent Developments and Future Plans
2.3 Ethicon, Inc. (U.S.)
2.3.1 Ethicon, Inc. (U.S.) Details
2.3.2 Ethicon, Inc. (U.S.) Major Business
2.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Product and Solutions
2.3.4 Ethicon, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Ethicon, Inc. (U.S.) Recent Developments and Future Plans
2.4 Medtronic (U.S.)
2.4.1 Medtronic (U.S.) Details
2.4.2 Medtronic (U.S.) Major Business
2.4.3 Medtronic (U.S.) Obesity Treatment Product and Solutions
2.4.4 Medtronic (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Medtronic (U.S.) Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche (Switzerland)
2.5.1 F. Hoffmann-La Roche (Switzerland) Details
2.5.2 F. Hoffmann-La Roche (Switzerland) Major Business
2.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product and Solutions
2.5.4 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 F. Hoffmann-La Roche (Switzerland) Recent Developments and Future Plans
2.6 Atkins Nutritionals, Inc. (U.S.)
2.6.1 Atkins Nutritionals, Inc. (U.S.) Details
2.6.2 Atkins Nutritionals, Inc. (U.S.) Major Business
2.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product and Solutions
2.6.4 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Atkins Nutritionals, Inc. (U.S.) Recent Developments and Future Plans
2.7 Herbalife Ltd. (U.S.)
2.7.1 Herbalife Ltd. (U.S.) Details
2.7.2 Herbalife Ltd. (U.S.) Major Business
2.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Product and Solutions
2.7.4 Herbalife Ltd. (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Herbalife Ltd. (U.S.) Recent Developments and Future Plans
2.8 Covidien plc (U.S.)
2.8.1 Covidien plc (U.S.) Details
2.8.2 Covidien plc (U.S.) Major Business
2.8.3 Covidien plc (U.S.) Obesity Treatment Product and Solutions
2.8.4 Covidien plc (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Covidien plc (U.S.) Recent Developments and Future Plans
2.9 Apollo Endosurgery (U.S.)
2.9.1 Apollo Endosurgery (U.S.) Details
2.9.2 Apollo Endosurgery (U.S.) Major Business
2.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Product and Solutions
2.9.4 Apollo Endosurgery (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Apollo Endosurgery (U.S.) Recent Developments and Future Plans
2.10 Amer Sports (Finland)
2.10.1 Amer Sports (Finland) Details
2.10.2 Amer Sports (Finland) Major Business
2.10.3 Amer Sports (Finland) Obesity Treatment Product and Solutions
2.10.4 Amer Sports (Finland) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Amer Sports (Finland) Recent Developments and Future Plans
2.11 Johnson Health Technology, Ltd. (Taiwan)
2.11.1 Johnson Health Technology, Ltd. (Taiwan) Details
2.11.2 Johnson Health Technology, Ltd. (Taiwan) Major Business
2.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product and Solutions
2.11.4 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Johnson Health Technology, Ltd. (Taiwan) Recent Developments and Future Plans
2.12 Cybex International (U.S.)
2.12.1 Cybex International (U.S.) Details
2.12.2 Cybex International (U.S.) Major Business
2.12.3 Cybex International (U.S.) Obesity Treatment Product and Solutions
2.12.4 Cybex International (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Cybex International (U.S.) Recent Developments and Future Plans
2.13 USGI Medical (U.S.)
2.13.1 USGI Medical (U.S.) Details
2.13.2 USGI Medical (U.S.) Major Business
2.13.3 USGI Medical (U.S.) Obesity Treatment Product and Solutions
2.13.4 USGI Medical (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 USGI Medical (U.S.) Recent Developments and Future Plans
2.14 Olympus Corporation (Japan)
2.14.1 Olympus Corporation (Japan) Details
2.14.2 Olympus Corporation (Japan) Major Business
2.14.3 Olympus Corporation (Japan) Obesity Treatment Product and Solutions
2.14.4 Olympus Corporation (Japan) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Olympus Corporation (Japan) Recent Developments and Future Plans
2.15 Brunswick Corporation (U.S.)
2.15.1 Brunswick Corporation (U.S.) Details
2.15.2 Brunswick Corporation (U.S.) Major Business
2.15.3 Brunswick Corporation (U.S.) Obesity Treatment Product and Solutions
2.15.4 Brunswick Corporation (U.S.) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Brunswick Corporation (U.S.) Recent Developments and Future Plans
2.16 Technogym SpA (Italy)
2.16.1 Technogym SpA (Italy) Details
2.16.2 Technogym SpA (Italy) Major Business
2.16.3 Technogym SpA (Italy) Obesity Treatment Product and Solutions
2.16.4 Technogym SpA (Italy) Obesity Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Technogym SpA (Italy) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Obesity Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Obesity Treatment Players Market Share
3.2.2 Top 10 Obesity Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Obesity Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Obesity Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Obesity Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Obesity Treatment Revenue Market Share by Application (2016-2021)
5.2 Obesity Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Obesity Treatment Revenue by Type (2016-2026)
6.2 North America Obesity Treatment Revenue by Application (2016-2026)
6.3 North America Obesity Treatment Market Size by Country
6.3.1 North America Obesity Treatment Revenue by Country (2016-2026)
6.3.2 United States Obesity Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Obesity Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Obesity Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Obesity Treatment Revenue by Type (2016-2026)
7.2 Europe Obesity Treatment Revenue by Application (2016-2026)
7.3 Europe Obesity Treatment Market Size by Country
7.3.1 Europe Obesity Treatment Revenue by Country (2016-2026)
7.3.2 Germany Obesity Treatment Market Size and Forecast (2016-2026)
7.3.3 France Obesity Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Obesity Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Obesity Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Obesity Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Obesity Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Obesity Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Obesity Treatment Market Size by Region
8.3.1 Asia-Pacific Obesity Treatment Revenue by Region (2016-2026)
8.3.2 China Obesity Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Obesity Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Obesity Treatment Market Size and Forecast (2016-2026)
8.3.5 India Obesity Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Obesity Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Obesity Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Obesity Treatment Revenue by Type (2016-2026)
9.2 South America Obesity Treatment Revenue by Application (2016-2026)
9.3 South America Obesity Treatment Market Size by Country
9.3.1 South America Obesity Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Obesity Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Obesity Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Obesity Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Obesity Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Obesity Treatment Market Size by Country
10.3.1 Middle East & Africa Obesity Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Obesity Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Obesity Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Obesity Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Obesity Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Obesity Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Obesity Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Obesity Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Obesity Treatment Revenue Market Share by Region (2021-2026)
Table 6. NutriSystem, Inc. (U.S.) Corporate Information, Head Office, and Major Competitors
Table 7. NutriSystem, Inc. (U.S.) Major Business
Table 8. NutriSystem, Inc. (U.S.) Obesity Treatment Product and Solutions
Table 9. NutriSystem, Inc. (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Kellogg Company (U.S.) Corporate Information, Head Office, and Major Competitors
Table 11. Kellogg Company (U.S.) Major Business
Table 12. Kellogg Company (U.S.) Obesity Treatment Product and Solutions
Table 13. Kellogg Company (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Ethicon, Inc. (U.S.) Corporate Information, Head Office, and Major Competitors
Table 15. Ethicon, Inc. (U.S.) Major Business
Table 16. Ethicon, Inc. (U.S.) Obesity Treatment Product and Solutions
Table 17. Ethicon, Inc. (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Medtronic (U.S.) Corporate Information, Head Office, and Major Competitors
Table 19. Medtronic (U.S.) Major Business
Table 20. Medtronic (U.S.) Obesity Treatment Product and Solutions
Table 21. Medtronic (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. F. Hoffmann-La Roche (Switzerland) Corporate Information, Head Office, and Major Competitors
Table 23. F. Hoffmann-La Roche (Switzerland) Major Business
Table 24. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product and Solutions
Table 25. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Atkins Nutritionals, Inc. (U.S.) Corporate Information, Head Office, and Major Competitors
Table 27. Atkins Nutritionals, Inc. (U.S.) Major Business
Table 28. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product and Solutions
Table 29. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Herbalife Ltd. (U.S.) Corporate Information, Head Office, and Major Competitors
Table 31. Herbalife Ltd. (U.S.) Major Business
Table 32. Herbalife Ltd. (U.S.) Obesity Treatment Product and Solutions
Table 33. Herbalife Ltd. (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Covidien plc (U.S.) Corporate Information, Head Office, and Major Competitors
Table 35. Covidien plc (U.S.) Major Business
Table 36. Covidien plc (U.S.) Obesity Treatment Product and Solutions
Table 37. Covidien plc (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Apollo Endosurgery (U.S.) Corporate Information, Head Office, and Major Competitors
Table 39. Apollo Endosurgery (U.S.) Major Business
Table 40. Apollo Endosurgery (U.S.) Obesity Treatment Product and Solutions
Table 41. Apollo Endosurgery (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Amer Sports (Finland) Corporate Information, Head Office, and Major Competitors
Table 43. Amer Sports (Finland) Major Business
Table 44. Amer Sports (Finland) Obesity Treatment Product and Solutions
Table 45. Amer Sports (Finland) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Johnson Health Technology, Ltd. (Taiwan) Corporate Information, Head Office, and Major Competitors
Table 47. Johnson Health Technology, Ltd. (Taiwan) Major Business
Table 48. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product and Solutions
Table 49. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Cybex International (U.S.) Corporate Information, Head Office, and Major Competitors
Table 51. Cybex International (U.S.) Major Business
Table 52. Cybex International (U.S.) Obesity Treatment Product and Solutions
Table 53. Cybex International (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. USGI Medical (U.S.) Corporate Information, Head Office, and Major Competitors
Table 55. USGI Medical (U.S.) Major Business
Table 56. USGI Medical (U.S.) Obesity Treatment Product and Solutions
Table 57. USGI Medical (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Olympus Corporation (Japan) Corporate Information, Head Office, and Major Competitors
Table 59. Olympus Corporation (Japan) Major Business
Table 60. Olympus Corporation (Japan) Obesity Treatment Product and Solutions
Table 61. Olympus Corporation (Japan) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Brunswick Corporation (U.S.) Corporate Information, Head Office, and Major Competitors
Table 63. Brunswick Corporation (U.S.) Major Business
Table 64. Brunswick Corporation (U.S.) Obesity Treatment Product and Solutions
Table 65. Brunswick Corporation (U.S.) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Technogym SpA (Italy) Corporate Information, Head Office, and Major Competitors
Table 67. Technogym SpA (Italy) Major Business
Table 68. Technogym SpA (Italy) Obesity Treatment Product and Solutions
Table 69. Technogym SpA (Italy) Obesity Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Obesity Treatment Revenue (USD Million) by Players (2019-2021)
Table 71. Global Obesity Treatment Revenue Share by Players (2019-2021)
Table 72. Breakdown of Obesity Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Obesity Treatment Players Head Office, Products and Services Provided
Table 74. Obesity Treatment Mergers & Acquisitions in the Past Five Years
Table 75. Obesity Treatment New Entrants and Expansion Plans
Table 76. Global Obesity Treatment Revenue (USD Million) by Type (2016-2021)
Table 77. Global Obesity Treatment Revenue Share by Type (2016-2021)
Table 78. Global Obesity Treatment Revenue Forecast by Type (2021-2026)
Table 79. Global Obesity Treatment Revenue by Application (2016-2021)
Table 80. Global Obesity Treatment Revenue Forecast by Application (2021-2026)
Table 81. North America Obesity Treatment Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Obesity Treatment Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Obesity Treatment Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Obesity Treatment Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Obesity Treatment Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Obesity Treatment Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Obesity Treatment Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Obesity Treatment Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Obesity Treatment Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Obesity Treatment Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Obesity Treatment Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Obesity Treatment Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Obesity Treatment Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Obesity Treatment Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Obesity Treatment Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Obesity Treatment Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Obesity Treatment Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Obesity Treatment Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Obesity Treatment Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Obesity Treatment Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Obesity Treatment Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Obesity Treatment Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Obesity Treatment Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Obesity Treatment Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Obesity Treatment Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Obesity Treatment Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Obesity Treatment Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Obesity Treatment Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Obesity Treatment Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Obesity Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Obesity Treatment Picture
Figure 2. Global Obesity Treatment Revenue Market Share by Type in 2020
Figure 3. Surgical & Implant Devices
Figure 4. Medication Therapy
Figure 5. Dietary
Figure 6. Other
Figure 7. Obesity Treatment Revenue Market Share by Application in 2020
Figure 8. Children Picture
Figure 9. Adults Picture
Figure 10. Global Obesity Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Obesity Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Obesity Treatment Revenue Market Share by Region (2016-2026)
Figure 13. Global Obesity Treatment Revenue Market Share by Region in 2020
Figure 14. North America Obesity Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Obesity Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Obesity Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Obesity Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Obesity Treatment Market Drivers
Figure 19. Obesity Treatment Market Restraints
Figure 20. Obesity Treatment Market Trends
Figure 21. NutriSystem, Inc. (U.S.) Recent Developments and Future Plans
Figure 22. Kellogg Company (U.S.) Recent Developments and Future Plans
Figure 23. Ethicon, Inc. (U.S.) Recent Developments and Future Plans
Figure 24. Medtronic (U.S.) Recent Developments and Future Plans
Figure 25. F. Hoffmann-La Roche (Switzerland) Recent Developments and Future Plans
Figure 26. Atkins Nutritionals, Inc. (U.S.) Recent Developments and Future Plans
Figure 27. Herbalife Ltd. (U.S.) Recent Developments and Future Plans
Figure 28. Covidien plc (U.S.) Recent Developments and Future Plans
Figure 29. Apollo Endosurgery (U.S.) Recent Developments and Future Plans
Figure 30. Amer Sports (Finland) Recent Developments and Future Plans
Figure 31. Johnson Health Technology, Ltd. (Taiwan) Recent Developments and Future Plans
Figure 32. Cybex International (U.S.) Recent Developments and Future Plans
Figure 33. USGI Medical (U.S.) Recent Developments and Future Plans
Figure 34. Olympus Corporation (Japan) Recent Developments and Future Plans
Figure 35. Brunswick Corporation (U.S.) Recent Developments and Future Plans
Figure 36. Technogym SpA (Italy) Recent Developments and Future Plans
Figure 38. Global Obesity Treatment Revenue Share by Players in 2020
Figure 39. Obesity Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Obesity Treatment Revenue Market Share in 2020
Figure 41. Global Top 10 Players Obesity Treatment Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Obesity Treatment Revenue Share by Type in 2020
Figure 44. Global Obesity Treatment Market Share Forecast by Type (2021-2026)
Figure 45. Global Obesity Treatment Revenue Share by Application in 2020
Figure 46. Global Obesity Treatment Market Share Forecast by Application (2021-2026)
Figure 47. North America Obesity Treatment Sales Market Share by Type (2016-2026)
Figure 48. North America Obesity Treatment Sales Market Share by Application (2016-2026)
Figure 49. North America Obesity Treatment Revenue Market Share by Country (2016-2026)
Figure 50. United States Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Obesity Treatment Sales Market Share by Type (2016-2026)
Figure 54. Europe Obesity Treatment Sales Market Share by Application (2016-2026)
Figure 55. Europe Obesity Treatment Revenue Market Share by Country (2016-2026)
Figure 56. Germany Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Obesity Treatment Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Obesity Treatment Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Obesity Treatment Revenue Market Share by Region (2016-2026)
Figure 64. China Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Obesity Treatment Sales Market Share by Type (2016-2026)
Figure 71. South America Obesity Treatment Sales Market Share by Application (2016-2026)
Figure 72. South America Obesity Treatment Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Obesity Treatment Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Obesity Treatment Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Obesity Treatment Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Obesity Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の肥満治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Obesity Treatment Market The global Obesity Treatment market size is projected to reach US$ 11930 million by 2026, from US$ 4912 million in 2019, at a CAGR of 13.4% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report …- 世界の肥満管理市場規模・現状・予測（2021年-2027年） Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed wor…
- 世界の抗肥満薬市場 2021：企業別、地域別、種類・用途別 The Anti-Obesity Drugs (Anti-obesity Medication) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の肥満介入装置市場規模・現状・予測（2021年-2027年） Obesity is a medical condition caused by an increase in fat cells in the body, which can have a negative impact on health. High blood pressure, high cholesterol and heart disease are serious medical conditions associated with obesity. Obesity also increases the risk of certain diseases, such as type…
- 世界の肥満手術用装置市場 2021：企業別、地域別、種類・用途別 The Obesity Surgery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…